Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Immuno-Oncology-Congress-2021-1000x250px

The ESMO Immuno-Oncology 2021 programme is now online!

Access the online programme

Learning objectives

  • Update your knowledge on the fast-developing field of cancer immunotherapy and related biomarkers
  • Understand what is in progress on immune modulation beyond checkpoint inhibition, focusing on tumour microenvironment, cellular-based approaches, genetic T-cell engineering and microbiome.
  • Review state-of-the-art diagnostic, biomarker and therapeutic strategies in immune-oncology, applicable to the most frequent cancers
  • Be informed on emerging evidence and research on immunotherapies in combination with other anti-cancer targeted therapies

Accreditation

ESMO-MORA: The ESMO Immuno-Oncology 2021 programme will be submitted for ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.

Webcasts

The congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings